Global Oral Contraceptive Pills Market
Pharmaceuticals

CAGR of 14.9% Projected for Oral Contraceptive Pills Market From 2025 to 2029

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Oral Contraceptive Pills Market Evolve in Terms of Growth and Size by 2029?

The dimension of the oral contraceptive pills market has seen tremendous growth in the past few years. The market is predicted to expand from $26.82 billion in 2024 to $30.43 billion in 2025, marking a compound annual growth rate (CAGR) of 13.5%. The considerable growth observed during the historic period can be credited to factors such as improved awareness, escalating concerns about women’s health, initiatives by the government, alterations in lifestyle patterns, and market broadening.

The market size for oral contraceptive pills is predicted to undergo significant expansion in the upcoming years and is set to reach “$53.07 billion by 2029, witnessing a compound annual growth rate (CAGR) of 14.9%.” Factors contributing to this projected growth during the predicted period include a growing population, the empowerment of women, increased healthcare spending, improvements in healthcare infrastructure, and a broadening product range. The forecast period also sees trends focusing on reducing side effects and hormonal imbalances, the arrival of natural and non-hormonal contraceptive alternatives, a shift to continuous and customized contraceptive plans, intensifying education and awareness initiatives, and a surge in female engagement and decision-making in contraceptive choices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp

What factors are expected to fuel Oral Contraceptive Pills market growth in the coming years?

The prevalence of unplanned pregnancies is anticipated to bolster the expansion of the oral contraceptive pills market in the forthcoming years. An unplanned pregnancy refers to one that has not been desired, such as instances where no children were planned. A study conducted by the University of California, San Francisco (UCSF) revealed that the turnout of unwanted pregnancies and abortion significantly dropped when women were given a year-long prescription of oral contraceptive pills. The World Health Organization (WHO) reports suggest that there are 74 million women in low to middle-income countries recording unplanned pregnancies annually across the world. Upon observation, the WHO discovered that 4,794 women experienced unplanned pregnancies after they stopped using contraceptive measures. As such, the requirement to evade unintended pregnancies propels the growth of the oral contraceptive pills market.

The oral contraceptive pills market covered in this report is segmented –

1) By Type: Combination, Progestin Only, Other Types

2) By Category: Generic, Branded

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels

Subsegments:

1) By Combination Pills: Monophasic Combination Pills, Multiphasic Combination Pills, Extended-Cycle Combination Pills

2) By Progestin-Only Pills: Daily Progestin-Only Pills, Progestin-Only Emergency Contraceptive Pills

3) By Other Types: Low-Dose Oral Contraceptive Pills, High-Dose Oral Contraceptive Pills, Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)

What Are The Leading Trends And Opportunities In The Oral Contraceptive Pills Sector?

Significant organizations and corporations in the oral contraceptive pill industry are concentrating on the creation of innovative solutions for oral contraceptive pills. For illustration, the United Kingdom initiated clinical trials in December 2023 for a contraceptive pill devoid of male hormones. This precedent-setting trial marks the research team in the nation as a global frontrunner in the study of this revolutionary drug type. The drug in focus is YCT-529, which acts as a retinoic acid receptor-alpha suppressor. Its functioning model halts sperm production by restricting the availability of vitamin A. The drug’s invention is credited to a research team from the University of Minnesota in Minneapolis.

What Are The Most Active Companies In The Oral Contraceptive Pills Market Today?

Major companies operating in the oral contraceptive pills market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbvie Inc., Bayer AG, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals, Mankind Pharma Ltd., Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Mylan N.V., Novartis AG, GlaxoSmithKline plc, Piramal Enterprises Ltd., Syzygy Healthcare, V Care Pharma

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Which Regional Markets Are Attracting The Most Investment In Oral Contraceptive Pills?

North America was the largest region in the oral contraceptive pills market in 2024. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3900&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model